Myeloablative Transplantation using either Cord Blood or Bone Marrow leads to Immune Recovery, High Long-Term Donor Chimerism and Excellent Survival in Chronic Granulomatous Disease
作者单位:The Emmes Corporation, Rockville, MD, United States[1]Pediatric Blood and Marrow Transplantation Program, Duke University Medical Center, Durham, NC[2]National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD[3]